Singapore markets close in 3 hours 35 minutes

Hyloris Pharmaceuticals SA (52U.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
11.400.00 (0.00%)
At close: 08:22AM CEST
Full screen
Previous close11.40
Open11.40
Bid0.00 x N/A
Ask0.00 x N/A
Day's range11.40 - 11.40
52-week range10.60 - 13.35
Volume80
Avg. volume12
Market cap327.604M
Beta (5Y monthly)0.58
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Reuters

    Hyloris Pharma wins US FDA approval for pain treatment

    The U.S. health regulator has approved Hyloris Pharmaceuticals' drug for post-operative pain, the Belgium-based company said on Wednesday, adding that it expects to launch the non-opioid treatment in the United States by early next year. The injectable drug, branded as Maxigesic IV, was approved as a post-operative drug in hospitals or when patients cannot take medicine orally. Maxigesic IV, a combination of paracetamol with ibuprofen solution for infusion, helps reduce pain and inflammation without the risk of opioid addiction that resulted in more than half a million deaths in the U.S. during 1999 to 2020.